Site US10023 — Scottsdale, Arizona

Site US10023 is a clinical research site located in Scottsdale, Arizona, United States 85259.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US10023 has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Scottsdale

Browse all research sites in Arizona · View every site in Scottsdale

• Mayo Clinic Hospital
• Scottsdale Healthcare Hospitals DBA Honor Health
• Mayo Clinic - Arizona Mayo Clinic Hospital
• University of Arizona, Banner Health
• Arizona State University-Honor Health Research Institute
• Greenbaum Surgical Specialty Hospital
• Mayo Clinic Hospital Scottsdale /ID# 278349
• Scottsdale Healthcare Hospitals d/b/a HonorHealth
• Scottsdale Healthcare Hospitals dba Honor Health Research Institute
• Scottsdale Healthcare Hospitals DBA HonorHealth
• Scottsdale Healthcare Hospitals
• Mayo Clinical Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10023?

Site US10023 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10023 conducted?

Site US10023 has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia.

Is Site US10023 accredited by Crixeo Clinical Trials?

Site US10023 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10023?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.